Pipeline Update: Mobileye Sets Terms; New Filings remain slow

NEW FILINGS

Company: Acrivon Therapeutics, Inc.
Symbol: ACRV (Nasdaq)
Description: They are a clinical stage biopharmaceutical company developing precision oncology medicines that we match to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing our proprietary proteomics-based patient responder identification platform.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriters: Morgan Stanley, Jefferies, Cowen, Piper Sandler
Link to Prospectus: Filed: 10-17-22

TERMS ADDED

Company: Mobileye Global Inc.
Symbol: MBLY (Nasdaq)
Description: Mobileye is a leader in the development and deployment of advanced driver assistance systems (“ADAS”) and autonomous driving technologies and solutions.
Shares: 41 million
Price Range: $18.00-$20.00
Market Cap: $14.3b-$15.9b
Trade Date: Wednesday, 10/26
Underwriters: Goldman Sachs, Morgan Stanley, Evercore ISI, Barclays, Citigroup, BofA Securities, RBC Capital Markets, Mizuho, Wolfe | Nomura Alliance, BNP PARIBAS
Co-Manager(s): Cowen, Siebert Williams Shank, PJT Partners, MUFG, Needham & Company, Raymond James, Loop Capital Markets, Blaylock Van, Academy Securities, Drexel Hamilton, Independence Point Securities, CICC, Cabrera Capital
Markets, Guzman & Company

Link to Prospectus:Terms Added: 10-18-22